Cargando…

IgM-associated gut bacteria in obesity and type 2 diabetes in C57BL/6 mice and humans

AIMS/HYPOTHESIS: IgM is the primary antibody produced by B cells and we hypothesise that IgM antibodies to gut microbiota may play a role in immunometabolism in obesity and type 2 diabetes. To test our hypothesis, we used B6 mice deficient in activation-induced cytidine deaminase (Aid(−/−) [also kno...

Descripción completa

Detalles Bibliográficos
Autores principales: Pearson, James A., Ding, Heyuan, Hu, Changyun, Peng, Jian, Galuppo, Brittany, Wong, F. Susan, Caprio, Sonia, Santoro, Nicola, Wen, Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9283171/
https://www.ncbi.nlm.nih.gov/pubmed/35587276
http://dx.doi.org/10.1007/s00125-022-05711-8
_version_ 1784747275721900032
author Pearson, James A.
Ding, Heyuan
Hu, Changyun
Peng, Jian
Galuppo, Brittany
Wong, F. Susan
Caprio, Sonia
Santoro, Nicola
Wen, Li
author_facet Pearson, James A.
Ding, Heyuan
Hu, Changyun
Peng, Jian
Galuppo, Brittany
Wong, F. Susan
Caprio, Sonia
Santoro, Nicola
Wen, Li
author_sort Pearson, James A.
collection PubMed
description AIMS/HYPOTHESIS: IgM is the primary antibody produced by B cells and we hypothesise that IgM antibodies to gut microbiota may play a role in immunometabolism in obesity and type 2 diabetes. To test our hypothesis, we used B6 mice deficient in activation-induced cytidine deaminase (Aid(−/−) [also known as Aicda(−/−)]) which secrete only IgM antibodies, and human faecal samples. METHODS: We studied the immunometabolic effects and gut microbial changes in high-fat-diet-induced obesity (HFDIO) in Aid(−/−) B6 mice compared with wild-type mice. To determine similarities between mice and humans, human stool samples were collected from children and adolescents who were obese with normal glucose tolerance (NGT), obese with glucose intolerance (IGT), or obese and newly diagnosed with type 2 diabetes, for faecal microbiota transplant (FMT) into germ-free (GF) B6 mice and we assessed IgM-bound bacteria and immune responses. RESULTS: Compared with wild-type mice, Aid(−/−) B6 mice developed exacerbated HFDIO due to abundant levels of IgM. FMT from Aid(−/−) B6 to GF B6 mice promoted greater weight gain in recipient mice compared with FMT using wild-type mouse faecal microbiota. Obese youth with type 2 diabetes had more IgM-bound gut bacteria. Using the stools from the obese youth with type 2 diabetes for FMT to GF B6 mice, we observed that the gut microbiota promoted body weight gain and impaired glucose tolerance in the recipient GF B6 mice. Importantly, some clinical features of these obese young individuals were mirrored in the GF B6 mice following FMT. CONCLUSIONS/INTERPRETATION: Our results suggest that IgM-bound gut microbiota may play an important role in the immuno-pathogenesis of obesity and type 2 diabetes, and provide a novel link between IgM in obesity and type 2 diabetes in both mice and humans. DATA AVAILABILITY: The 16s rRNA sequencing datasets supporting the current study have been deposited in the NCBI SRA public repository (https://www.ncbi.nlm.nih.gov/sra; accession no. SAMN18796639). GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains peer-reviewed but unedited supplementary material available at 10.1007/s00125-022-05711-8.
format Online
Article
Text
id pubmed-9283171
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-92831712022-07-16 IgM-associated gut bacteria in obesity and type 2 diabetes in C57BL/6 mice and humans Pearson, James A. Ding, Heyuan Hu, Changyun Peng, Jian Galuppo, Brittany Wong, F. Susan Caprio, Sonia Santoro, Nicola Wen, Li Diabetologia Article AIMS/HYPOTHESIS: IgM is the primary antibody produced by B cells and we hypothesise that IgM antibodies to gut microbiota may play a role in immunometabolism in obesity and type 2 diabetes. To test our hypothesis, we used B6 mice deficient in activation-induced cytidine deaminase (Aid(−/−) [also known as Aicda(−/−)]) which secrete only IgM antibodies, and human faecal samples. METHODS: We studied the immunometabolic effects and gut microbial changes in high-fat-diet-induced obesity (HFDIO) in Aid(−/−) B6 mice compared with wild-type mice. To determine similarities between mice and humans, human stool samples were collected from children and adolescents who were obese with normal glucose tolerance (NGT), obese with glucose intolerance (IGT), or obese and newly diagnosed with type 2 diabetes, for faecal microbiota transplant (FMT) into germ-free (GF) B6 mice and we assessed IgM-bound bacteria and immune responses. RESULTS: Compared with wild-type mice, Aid(−/−) B6 mice developed exacerbated HFDIO due to abundant levels of IgM. FMT from Aid(−/−) B6 to GF B6 mice promoted greater weight gain in recipient mice compared with FMT using wild-type mouse faecal microbiota. Obese youth with type 2 diabetes had more IgM-bound gut bacteria. Using the stools from the obese youth with type 2 diabetes for FMT to GF B6 mice, we observed that the gut microbiota promoted body weight gain and impaired glucose tolerance in the recipient GF B6 mice. Importantly, some clinical features of these obese young individuals were mirrored in the GF B6 mice following FMT. CONCLUSIONS/INTERPRETATION: Our results suggest that IgM-bound gut microbiota may play an important role in the immuno-pathogenesis of obesity and type 2 diabetes, and provide a novel link between IgM in obesity and type 2 diabetes in both mice and humans. DATA AVAILABILITY: The 16s rRNA sequencing datasets supporting the current study have been deposited in the NCBI SRA public repository (https://www.ncbi.nlm.nih.gov/sra; accession no. SAMN18796639). GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains peer-reviewed but unedited supplementary material available at 10.1007/s00125-022-05711-8. Springer Berlin Heidelberg 2022-05-19 2022 /pmc/articles/PMC9283171/ /pubmed/35587276 http://dx.doi.org/10.1007/s00125-022-05711-8 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Pearson, James A.
Ding, Heyuan
Hu, Changyun
Peng, Jian
Galuppo, Brittany
Wong, F. Susan
Caprio, Sonia
Santoro, Nicola
Wen, Li
IgM-associated gut bacteria in obesity and type 2 diabetes in C57BL/6 mice and humans
title IgM-associated gut bacteria in obesity and type 2 diabetes in C57BL/6 mice and humans
title_full IgM-associated gut bacteria in obesity and type 2 diabetes in C57BL/6 mice and humans
title_fullStr IgM-associated gut bacteria in obesity and type 2 diabetes in C57BL/6 mice and humans
title_full_unstemmed IgM-associated gut bacteria in obesity and type 2 diabetes in C57BL/6 mice and humans
title_short IgM-associated gut bacteria in obesity and type 2 diabetes in C57BL/6 mice and humans
title_sort igm-associated gut bacteria in obesity and type 2 diabetes in c57bl/6 mice and humans
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9283171/
https://www.ncbi.nlm.nih.gov/pubmed/35587276
http://dx.doi.org/10.1007/s00125-022-05711-8
work_keys_str_mv AT pearsonjamesa igmassociatedgutbacteriainobesityandtype2diabetesinc57bl6miceandhumans
AT dingheyuan igmassociatedgutbacteriainobesityandtype2diabetesinc57bl6miceandhumans
AT huchangyun igmassociatedgutbacteriainobesityandtype2diabetesinc57bl6miceandhumans
AT pengjian igmassociatedgutbacteriainobesityandtype2diabetesinc57bl6miceandhumans
AT galuppobrittany igmassociatedgutbacteriainobesityandtype2diabetesinc57bl6miceandhumans
AT wongfsusan igmassociatedgutbacteriainobesityandtype2diabetesinc57bl6miceandhumans
AT capriosonia igmassociatedgutbacteriainobesityandtype2diabetesinc57bl6miceandhumans
AT santoronicola igmassociatedgutbacteriainobesityandtype2diabetesinc57bl6miceandhumans
AT wenli igmassociatedgutbacteriainobesityandtype2diabetesinc57bl6miceandhumans